Thank you, Mr. Chair. I will share my time with my colleague Murray Rankin.
I want to thank the witnesses for their presentations.
The experts we have heard from so far agree that oversight mechanisms are essential to ensure the protection of vulnerable individuals. At what point in the physician-assisted dying process do you think that oversight should be provided? Would it be before the person receives assistance to die, or would the experience be analyzed only after the fact?